David Lassen Shares Insights on Prime/MRx Analysis on GLP-1 for Weight Loss in New Video
November 14, 2023
Earlier this year, Prime/Magellan Rx announced an analysis of GLP-1 drugs for weight loss, which found low adherence and increased cost among individuals taking the drug. In this video, David Lassen, Chief Clinical Officer, provides additional insights.